Fully Covered Removable Nitinol Self-expandable Metal Stents (SEMS) in Malignant Strictures of the Esophagus: a Multicenter Analysis

Overview

Journal Surg Endosc

Publisher Springer

Specialties Gastroenterology
General Surgery
Radiology

Date 2011 Dec 20

PMID 22179474

Citations 15

Authors

Jayant P Talreja

Mohamad A Eloubeidi

Bryan G Sauer

Basil S Al-Awabdy

Tercio Lopes

Michel Kahaleh

Vanessa M Shami

Affiliations

Soon will be listed here.

Abstract

Background: Fully covered esophageal self-expandable metallic stents (SEMS) often are used for palliation of malignant dysphagia. However, experience and data on these stents are still limited. The purpose of this multicenter study was to evaluate the efficacy and safety of fully covered nitinol SEMS in patients with malignant dysphagia.

Methods: 37 patients underwent placement of a SEMS during a 3 year period. Five patients underwent SEMS placement as a bridge to surgery: one for tracheoesophageal fistula in the setting of squamous cell carcinoma of the esophagus, one for perforation in setting of esophageal adenocarcinoma, 27 for unresectable esophageal cancer (16 adenocarcinoma, 11 squamous cell carcinoma), two for lung cancer, and one for breast-cancer-related esophageal strictures.

Results: SEMS placement was successful in all 37 patients. Immediate complications after stent deployment included chest pain (n = 6), severe heartburn (n = 1), and upper gastrointestinal bleeding requiring SEMS revision (n = 1). Dysphagia scores improved significantly from 3.2 ± 0.4 before stent placement to 1.4 ± 1.0 at 1 month (P < 0.0001), 1.1 ± 1.2 (P < 0.0001) at 3 months, and 1.3 ± 1.4 (P = 0.0018) at 6 months. The stent was removed in 11 patients (30%) for the following indications: resolution of stricture (n = 3), stent malfunction (n = 5), and stent migration (n = 3). After stent removal, three patients were restented, three underwent dilation, and two underwent PEG placement. Mean survival for the 37 patients after stent placement was 146.3 ± 143.6 (range, 13-680) days.

Conclusions: Our study suggests that fully covered SEMS placement improve dysphagia scores in patients with malignant strictures, particularly in the unresectable population. Further technical improvements in design to minimize long-term malfunction and migration are required.

Citing Articles

Development of a prognostic nomogram model for predicting outcomes in benign esophagogastric anastomotic stenosis treated with fluoroscopic balloon dilation.

Li X, Wang S, Ding X, Qi Y, Li X, Yin M Surg Endosc. 2025; 39(3):1583-1592.

PMID: 39762605 DOI: 10.1007/s00464-024-11497-0.

Untethered shape-changing devices in the gastrointestinal tract.

Liu W, Choi S, George D, Li L, Zhong Z, Zhang R Expert Opin Drug Deliv. 2023; 20(12):1801-1822.

PMID: 38044866 PMC: 10872387. DOI: 10.1080/17425247.2023.2291450.

Efficacy and Safety of Self-Expandable Metallic Stent Placement for Malignant Esophageal Fistula.

Izumi A, Yoshio T, Sasaki T, Ishioka M, Kizawa A, Ikenoyama Y J Clin Med. 2023; 12(18).

PMID: 37762800 PMC: 10532036. DOI: 10.3390/jcm12185859.

Self-Expanding Metallic Stents for Palliation of Esophageal Cancer: A Single Center Experience From Saudi Arabia.

Alzanbagi A, Qureshi L, Ahmed I, Tashkandi A, Khan M, Alhazmi G Cureus. 2022; 14(12):e32096.

PMID: 36467426 PMC: 9713855. DOI: 10.7759/cureus.32096.

Hemostasis of massive bleeding from esophageal tumor: A case report.

Kashintsev A, Rusanov D, Antipova M, Anisimov S, Granstrem O, Kokhanenko N World J Gastrointest Endosc. 2022; 14(10):636-641.

PMID: 36303813 PMC: 9593517. DOI: 10.4253/wjge.v14.i10.636.

References

Watson A . Surgery for carcinoma of the oesophagus. Postgrad Med J. 1988; 64(757):860-4. PMC: 2429049. DOI: 10.1136/pgmj.64.757.860. View

Conio M, Repici A, Battaglia G, De Pretis G, Ghezzo L, Bittinger M . A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol. 2007; 102(12):2667-77. DOI: 10.1111/j.1572-0241.2007.01565.x. View

Lopes T, Eloubeidi M . A pilot study of fully covered self-expandable metal stents prior to neoadjuvant therapy for locally advanced esophageal cancer. Dis Esophagus. 2009; 23(4):309-15. DOI: 10.1111/j.1442-2050.2009.01011.x. View

Siersema P, Hop W, van Blankenstein M, van Tilburg A, Bac D, Homs M . A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc. 2001; 54(2):145-53. DOI: 10.1067/mge.2001.116879. View

Dua K . Stents for palliating malignant dysphagia and fistula: is the paradigm shifting?. Gastrointest Endosc. 2006; 65(1):77-81. DOI: 10.1016/j.gie.2006.07.016. View

Szegedi L, Gal I, Kosa I, Kiss G . Palliative treatment of esophageal carcinoma with self-expanding plastic stents: a report on 69 cases. Eur J Gastroenterol Hepatol. 2006; 18(11):1197-201. DOI: 10.1097/01.meg.0000236886.67085.2e. View

Enzinger P, Mayer R . Esophageal cancer. N Engl J Med. 2003; 349(23):2241-52. DOI: 10.1056/NEJMra035010. View

Sabharwal T, Hamady M, Chui S, Atkinson S, Mason R, Adam A . A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut. 2003; 52(7):922-6. PMC: 1773700. DOI: 10.1136/gut.52.7.922. View

Siersema P . Treatment options for esophageal strictures. Nat Clin Pract Gastroenterol Hepatol. 2008; 5(3):142-52. DOI: 10.1038/ncpgasthep1053. View

10.

Uitdehaag M, van Hooft J, Verschuur E, Repici A, Steyerberg E, Fockens P . A fully-covered stent (Alimaxx-E) for the palliation of malignant dysphagia: a prospective follow-up study. Gastrointest Endosc. 2009; 70(6):1082-9. DOI: 10.1016/j.gie.2009.05.032. View

11.

De Palma G, Di Matteo E, Romano G, Fimmano A, Rondinone G, Catanzano C . Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: a controlled prospective study. Gastrointest Endosc. 1996; 43(5):478-82. DOI: 10.1016/s0016-5107(96)70290-0. View

12.

Verschuur E, Repici A, Kuipers E, Steyerberg E, Siersema P . New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol. 2007; 103(2):304-12. DOI: 10.1111/j.1572-0241.2007.01542.x. View

13.

Karbowski M, Schembre D, Kozarek R, Ayub K, Low D . Polyflex self-expanding, removable plastic stents: assessment of treatment efficacy and safety in a variety of benign and malignant conditions of the esophagus. Surg Endosc. 2007; 22(5):1326-33. DOI: 10.1007/s00464-007-9644-7. View

14.

Wong R, Malthaner R . Esophageal cancer: a systematic review. Curr Probl Cancer. 2001; 24(6):297-373. DOI: 10.1016/s0147-0272(00)80002-1. View

15.

Berrino F, Gatta G, Chessa E, Valente F, Capocaccia R . Introduction: the EUROCARE II Study. Eur J Cancer. 1999; 34(14 Spec No):2139-53. DOI: 10.1016/s0959-8049(98)00334-7. View

16.

Elphick D, Smith B, Bagshaw J, Riley S . Self-expanding metal stents in the palliation of malignant dysphagia: outcome analysis in 100 consecutive patients. Dis Esophagus. 2005; 18(2):93-5. DOI: 10.1111/j.1442-2050.2005.00458.x. View

17.

Eloubeidi M, Lopes T . Novel removable internally fully covered self-expanding metal esophageal stent: feasibility, technique of removal, and tissue response in humans. Am J Gastroenterol. 2009; 104(6):1374-81. DOI: 10.1038/ajg.2009.133. View

18.

Vakil N, Morris A, Marcon N, Segalin A, Peracchia A, Bethge N . A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol. 2001; 96(6):1791-6. DOI: 10.1111/j.1572-0241.2001.03923.x. View

19.

Keller R, Flieger D, Fischbach W, Christl S . Self-expanding metal stents for malignant esophagogastric obstruction: experience with a new design covered nitinol stent. J Gastrointestin Liver Dis. 2007; 16(3):239-43. View

20.

Siersema P, Hop W, Dees J, Tilanus H, van Blankenstein M . Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest Endosc. 1998; 47(2):113-20. DOI: 10.1016/s0016-5107(98)70342-6. View